Magnetically navigated and near-infrared programmable nanoinducers for co-activating pyroptosis and ferroptosis in antitumor immunotherapy

View at publisher
Authors: Shengze Lu, Xiaopeng Hao, Haidong Zhao, Liangquan Yang, Zhengyi Liu, Hehua Cui, Ningyue Yu, Jingchao Li, Rujia Fan, Yang Yu
Cited by: 2
References: 62

Abstract

nanoparticles catalyze the Fenton reaction to induce intracellular ferroptosis, while the released pyroptotic antigens can recruit immune cells and sensitize the immune system. Through such a magnetic navigation and programmable controlled release mechanism, a potent antitumor immunological effect is triggered by the synergy of PTT, ferroptosis and pyroptosis immunotherapy. Therefore, tumor growth in subcutaneous breast cancer mouse models is significantly inhibited and survival rates are markedly improved. By combining with programmed death-ligand 1 antibody (aPD-L1) immunotherapy, SP@CSFe can trigger an immunological memory to suppress tumor recurrence. This study offers a magnetically targeted and programmable nanoinducer to integrate PTT ablation with pyroptosis-ferroptosis-induced immunogenic effects for effective and precise cancer therapy.

Fields of Study & Subjects

Nanoplatforms for cancer theranostics Inflammasome and immune disorders Bladder and Urothelial Cancer Treatments

Publication details

Journal / source
Materials Horizons
Publisher
Royal Society of Chemistry (RSC)
Volume
13
Issue
9
Pages
4405–4420
Publication date
1 January 2026
Language
EN